Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Chemistry Chair for Institute of Process Research and Development Monday 11 July 2011

Published: Wednesday, July 13, 2011
Last Updated: Wednesday, July 13, 2011
Bookmark and Share
Professor Frans L Muller has been appointed as Chair in Chemical Process Engineering at the University of Leeds.

Professor Frans L Muller has been appointed as Chair in Chemical Process Engineering at the University of Leeds. He will be based in the Institute of Process Research and Development (iPRD), which brings together experts from chemistry, engineering and industry to provide innovative new solutions for chemical manufacturing.

Professor Muller will oversee research into continuous flow processing, process modelling and simulation, and innovative ways of working in the process environment when he takes up his position on 1 August 2011.

Professor Muller said: “I am very pleased to join the team at iPRD. Having enjoyed working as a process engineer in compound development teams, I look forward to solving industrially relevant problems and helping train a new generation of process chemists and engineers with an aptitude for scale-up and manufacture.”

A much respected expert in the areas of agrochemical and pharmaceutical compound development, Professor Muller arrives at the Institute with a distinguished career. His academic studies began in Holland in 1983 where he studied Chemical Engineering at Delft University of Technology.

He then completed a PhD at the University of Cambridge with Professor John F Davidson before pursuing a substantial and varied career in industry. In 1994 he joined Zeneca Huddersfield (Later Syngenta) where he was involved in a project to write and develop ‘DynoChem’, a dynamic simulation package now used across the pharmaceutical industry.

After establishing himself as a Process Engineering Scientist in Syngenta, he moved to world-leading pharmaceutical company AstraZeneca in 2006 to become one of the first Associate Principle Scientists in process engineering.

Since then Professor Muller has helped bring large-scale thinking to early development through his invention of the scale-up risk evaluations and his work on the crystallization workflow concept. He is also currently the AstraZeneca project leader on F3 factory, a €30m euro pan-European project.

Professor John Blacker, iPRD Director in the Schools of Chemistry and Process, Material and Environmental Engineering at the University of Leeds, said: “This is a very exciting appointment for us which will strengthen our capabilities across the process chemical and engineering interface to enhance our ability to innovate in this area and reinforce the links iPRD is making between industry’s needs and creative academic problem solving.”

Established in 2008 by the University of Leeds’ transformation fund, the iPRD brings together expertise in chemistry and engineering in academia and industry to support manufacturing process innovation.

iPRD is partly funded by a £4.85 million investment from the European Regional Development Fund and Yorkshire Forward. The Institute houses a new £4.3 million process laboratory, which is the first of its kind in the UK.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Tuesday, July 28, 2015
New Insights into “Antenna” of Human Cells
Scientists from the University of Leeds have uncovered the most comprehensive list yet of genes implicated in a group of common inherited diseases.
Wednesday, July 15, 2015
Protein Responsible for Blood Vessel Growth in Tumours Discovered
Scientists have discovered a new protein which triggers the growth of blood vessels in breast cancer tumours which have spread to the brain, a common location which breast cancer can spread to.
Wednesday, July 01, 2015
Gold Nanotubes Launch A Three-Pronged Attack On Cancer Cells
Scientists have shown that gold nanotubes have many applications in fighting cancer: internal nanoprobes for high-resolution imaging; drug delivery vehicles; and agents for destroying cancer cells.
Monday, February 16, 2015
Stroke Damage Mechanism Identified
Researchers have discovered a mechanism linked to the brain damage often suffered by stroke victims—and are now searching for drugs to block it.
Monday, December 01, 2014
Breakthrough Allows Researchers to Watch Molecules “Wiggle”
A new crystallographic technique developed at the University of Leeds is set to transform scientists’ ability to observe how molecules work.
Tuesday, October 07, 2014
Scientists Develop Artificial Biominerals
Scientists have created synthetic crystals whose structures and properties mimic of naturally occurring biominerals.
Thursday, September 08, 2011
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!